Works matching IS 02692813 AND DT 2025 AND VI 61 AND IP 2

Results: 36

Letter: Should HBV Therapy Be Stopped Based on HBsAg Level Alone? Authors' Reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 404, doi. 10.1111/apt.18439

By:

Johannessen, Asgeir;
Reikvam, Dag Henrik;
Dalgard, Olav

Publication type:

Article

Letter: Real‐Life Evaluation of Effectiveness of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease Emphasises Importance of Appropriate Patient Selection and Centre Expertise—Authors' Reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 412, doi. 10.1111/apt.18432

By:

Bacsur, Péter;
Farkas, Klaudia;
Molnár, Tamás

Publication type:

Article

Letter: Real‐Life Evaluation of Effectiveness of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease Emphasises the Importance of Appropriate Patient Selection and Centre Expertise.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 410, doi. 10.1111/apt.18411

By:

Gao, Weilun;
Segal, Jonathan P.

Publication type:

Article

Editorial: Mesenchymal Stem Cell Therapy for Perianal Fistulising Crohn's Disease—Effective or Hype? Authors' Reply.

Published in:

2025

By:

Bacsur, Péter;
Farkas, Klaudia;
Molnár, Tamás

Publication type:

Editorial

Letter: Extending the Measurement of Inflammatory Bowel Disease Severity to Include Patient Important Outcomes—Authors' Reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 408, doi. 10.1111/apt.18421

By:

Swaminathan, Akhilesh;
Sparrow, Miles P.;
Gearry, Richard B.

Publication type:

Article

Clinical Trial: Treatment of Functional Dyspepsia According to Subtype Compared With Empirical Proton Pump Inhibitor.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 258, doi. 10.1111/apt.18418

By:

Chuah, Kee Huat;
Loo, Qing Yuan;
Hian, Wen Xuan;
Khoo, Xin Hui;
Panirsheeluam, Sarala;
Jubri, Nurhidayah Binti Mohammad;
Natarajan, Vicraman;
Khoo, Stanley;
Mahadeva, Sanjiv

Publication type:

Article

Letter: Towards Better Intervention Strategies for MASLD and MetALD—What Are We Missing? Authors' Reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 400, doi. 10.1111/apt.18412

By:

Park, Yewan;
Jung, Jooyi;
Kim, Gi‐Ae

Publication type:

Article

No Association Between Eosinophilic Oesophagitis and Oesophageal Cancer in US Adults: A Case–Control Study.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 363, doi. 10.1111/apt.18431

By:

Albaneze, Natasha;
Cotton, Cary C.;
Anderson, Chelsea;
Katzka, David A.;
Dellon, Evan S.

Publication type:

Article

Letter: Extending the Measurement of Inflammatory Bowel Disease Severity to Include Patient Important Outcomes.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 406, doi. 10.1111/apt.18410

By:

Forbes, Angela J.

Publication type:

Article

Editorial: Mesenchymal Stem Cell Therapy for Perianal Fistulising Crohn's Disease—Effective or Hype?

Published in:

2025

By:

McCurdy, Jeffrey D;
Wong, Serre‐yu

Publication type:

Case Study

Letter: Should HBV Therapy Be Stopped Based on HBsAg Level Alone?

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 402, doi. 10.1111/apt.18407

By:

Khan, Naeem A.;
Shah, Syed B.;
Choudhary, Umar I. J.;
Ullah, A.;
Ahmad, Saeed;
Patwardhan, V.

Publication type:

Article

Editorial: Updated COVID‐19 Boosters—Tailoring Protection for Patients With IBD. Authors' Reply.

Published in:

2025

By:

Woelfel, Simon;
Brand, Stephan

Publication type:

Editorial

Editorial: Rebuilding Rome—Revising Diagnostic Criteria for Irritable Bowel Syndrome.

Published in:

2025

By:

Butt, Mohsin F.;
Corsetti, Maura

Publication type:

Case Study

Letter: Integrating Psychological Profiles Into Dietary Interventions for IBS—Commentary on HADS Scores and Treatment Efficacy.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 396, doi. 10.1111/apt.18396

By:

Chen, Chia‐Wei;
Wei, Lien‐Chung

Publication type:

Article

Editorial: Assessing the Prognosis of Patients With HBV and ACLF—Comorbidities Matter. Authors' Reply.

Published in:

2025

By:

Yu, Jiong;
Chen, Xinyi;
Cao, Guoqiang;
Pan, Qiaoling;
Huang, Chenjie;
Luo, Rui;
Lu, Xiaoqing;
Chen, Xiaoxiao;
Li, Tan;
Huang, Haijun;
Wu, Jian;
Li, Lanjuan;
Cao, Hongcui

Publication type:

Editorial

Editorial: Is TIPSS Implantation Effective in Patients With Portal Hypertensive Gastropathy?

Published in:

2025

By:

Reincke, Marlene;
Thimme, Robert;
Bettinger, Dominik

Publication type:

Editorial

Meta‐Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Diseases.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 246, doi. 10.1111/apt.18390

By:

Carbery, Isabel;
Todd, Oliver;
Hale, Matthew;
Black, Christopher J.;
Clegg, Andrew;
Selinger, Christian P.

Publication type:

Article

Correction to 'Stromal Vascular Fraction With Platelet‐Rich Plasma Injection During Surgery is Feasible and Safe in Treatment‐Refractory Perianal Fistulising Crohn's Disease: A Pilot Study'.

Published in:: 2025
Publication type:: Correction Notice

Editorial: Understanding Factors Associated With Abdominal Pain in Ulcerative Colitis—No Surprises but the Usual Suspects Need Greater Attention. Authors' Reply.

Published in:

2025

By:

van Gils, Tom;
Törnblom, Hans;
Hreinsson, Jóhann P.;
Jonefjäll, Börje;
Strid, Hans;
Simrén, Magnus

Publication type:

Editorial

Editorial: Updated COVID‐19 Boosters—Tailoring Protection for Patients With IBD.

Published in:

2025

By:

Alexander, James L.;
Caldera, Freddy

Publication type:

Case Study

Letter: Towards Better Intervention Strategies for MASLD and MetALD—What Are We Missing?

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 398, doi. 10.1111/apt.18375

By:

Hu, Qiang;
Yang, Xiyin

Publication type:

Article

Editorial: Disentangling Early‐Life Antibiotics and Infections as Risk Factors for the Development of Childhood IBD.

Published in:

2025

By:

Stone, Katherine L.;
Faye, Adam S.

Publication type:

Editorial

Early‐Life Infections, Antibiotics and Later Risk of Childhood and Early Adult‐Onset Inflammatory Bowel Disease: Pooled Analysis of Two Scandinavian Birth Cohorts.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 323, doi. 10.1111/apt.18358

By:

Mårild, Karl;
Lerchova, Tereza;
Östensson, Malin;
Imberg, Henrik;
Størdal, Ketil;
Ludvigsson, Johnny

Publication type:

Article

Letter: Insulin‐Like Growth Factor‐1 in Cirrhosis Is Linked to Hepatic Dysfunction and Fibrogenesis and Predicts Liver‐Related Mortality.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 394, doi. 10.1111/apt.18366

By:

Tahir, Okasha;
Rafique, Muhammad Muzamil;
Khan, Abdul Ghani;
Rajab, Asia;
Alam, Umama;
Umar, Muhammad;
Shamim, Laiba;
Hidayat, Ayesha

Publication type:

Article

Portal Hypertensive Gastropathy and MELD‐Na Score Predict Recurrent Gastrointestinal Bleeding After TIPSS: An ALTA Group Study.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 346, doi. 10.1111/apt.18362

By:

Hu, Kelly;
Sedki, Mai;
Kwong, Allison;
Kesselman, Andrew;
Kolli, Kanti Pallav;
Morelli, Giuseppe;
Spengler, Erin;
Said, Adnan;
Lai, Jennifer;
Desai, Archita;
Paul, Sonali;
Frenette, Catherine;
Fallon, Michael;
German, Margarita;
Verna, Elizabeth;
Boike, Justin;
Gregory, Dyanna;
Thornburg, Bartley;
VanWagner, Lisa;
Goel, Aparna

Publication type:

Article

Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease?

Published in:

2025

By:

Papamichael, Konstantinos;
Cheifetz, Adam S.

Publication type:

Editorial

Editorial: Assessing the Prognosis of Patients With HBV and ACLF—Comorbidities Matter.

Published in:

2025

By:

Russo, Francesco Paolo;
Ferrarese, Alberto

Publication type:

Editorial

Evaluation of the Effectiveness and Safety of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease: An International Real‐Life Retrospective Multicentre Cohort Study.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 335, doi. 10.1111/apt.18359

By:

Bacsur, Péter;
Shaham, Daniel;
Serclova, Zuzana;
Resál, Tamás;
Farkas, Bernadett;
Sarlós, Patrícia;
Miheller, Pál;
Maharshak, Nitsan;
Zemel, Meir;
Shitrit, Ariella Bar‐Gil;
Yellinek, Shlomo;
Bálint, Anita;
Fábián, Anna;
Bor, Renáta;
Bősze, Zsófia;
Ivány, Emese;
Szepes, Zoltán;
Farkas, Klaudia;
Tóth, Illés;
Lázár, György

Publication type:

Article

Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 354, doi. 10.1111/apt.18363

By:

Goodoory, Vivek C.;
Riggott, Christy;
Khasawneh, Mais;
Black, Christopher J.;
Ford, Alexander C.

Publication type:

Article

Subcutaneous Infliximab Concentration Thresholds for Mucosal and Transmural Healing in Patients With Crohn's Disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 313, doi. 10.1111/apt.18354

By:

Hong, Sung Noh;
Song, Joo Hye;
Kim, Sung Jin;
Park, Yoon Ha;
Choi, Chang Wan;
Kim, Ji Eun;
Kim, Eun Ran;
Chang, Dong Kyung;
Kim, Young‐Ho

Publication type:

Article

XBB.1.5‐Adapted COVID‐19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS‐CoV‐2 JN.1 Variant in Patients With Inflammatory Bowel Disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 299, doi. 10.1111/apt.18349

By:

Woelfel, Simon;
Dütschler, Joel;
Junker, Daniel;
König, Marius;
Graf, Nicole;
Krieger, Claudia;
Truniger, Samuel;
Oikonomou, Vasileios;
Leinenkugel, Georg;
Koller, Seraina;
Metzger‐Peter, Katline;
Wyss, Jacqueline;
Krupka, Niklas;
Frei, Nicola;
Albrich, Werner C.;
Friedrich, Matthias;
Niess, Jan Hendrik;
Schneiderhan‐Marra, Nicole;
Dulovic, Alex;
Misselwitz, Benjamin

Publication type:

Article

Editorial: Understanding Factors Associated With Abdominal Pain in Ulcerative Colitis—No Surprises But the Usual Suspects Need Greater Attention.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 371, doi. 10.1111/apt.18353

By:

Gao, Weilun;
Segal, Jonathan P.

Publication type:

Article

aCCI‐HBV‐ACLF: A Novel Predictive Model for Hepatitis B Virus‐Related Acute‐On‐Chronic Liver Failure.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 286, doi. 10.1111/apt.18347

By:

Chen, Xinyi;
Gao, Feiqiong;
Pan, Qiaoling;
Huang, Chenjie;
Luo, Rui;
Lu, Xiaoqing;
Chen, Xiaoxiao;
Li, Tan;
Huang, Haijun;
Wu, Jian;
Yu, Jiong;
Li, Lanjuan;
Cao, Hongcui

Publication type:

Article

Prevalence of Low FIB‐4 in MASLD‐Related Hepatocellular Carcinoma: A Multicentre Study.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 278, doi. 10.1111/apt.18346

By:

Tan, Darren Jun Hao;
Tamaki, Nobuharu;
Kim, Beom Kyung;
Wijarnpreecha, Karn;
Aboona, Majd Bassam;
Faulkner, Claire;
Kench, Charlotte;
Salimi, Shirin;
Sabih, Abdul‐Hamid;
Lim, Wen Hui;
Danpanichkul, Pojsakorn;
Tay, Benjamin;
Teh, Yiqing;
Mok, John;
Nah, Benjamin;
Ng, Cheng Han;
Muthiah, Mark;
Kulkarni, Anand V.;
Lee, Sung Won;
Liu, Ken

Publication type:

Article

Issue Information.

Published in:: Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 243, doi. 10.1111/apt.18070
Publication type:: Article

Factors Associated With Abdominal Pain in Patients With Active and Quiescent Ulcerative Colitis: A Multicohort Study.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 268, doi. 10.1111/apt.18344

By:

van Gils, Tom;
Törnblom, Hans;
Hreinsson, Jóhann P.;
Jonefjäll, Börje;
Strid, Hans;
Simrén, Magnus

Publication type:

Article